• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login

    • Companion Diagnostic Companies

    ID: MRFR/MED/2231-CR
    168 Pages
    Rahul Gotadki
    February 2023

    Companion diagnostics are medical tests or devices that are developed alongside specific drugs to help determine the most effective treatment for individual patients. These tests identify biomarkers or genetic markers that are essential for predicting the safety and efficacy of a particular therapy.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Companion Diagnostics Market Research Report - Forecast till 2032 Infographic
    Summary Table of Contents Segmentation Infographic

    Top Industry Leaders in the Companion Diagnostic Market

    Companion Diagnostics Key CompaniesDisclaimer: List of key companies in no particular orderLatest Companion diagnostics Media Companies Update



    • June 2023: The upgraded xCELLigence RTCA Software Pro Version 2.8, a complete software suite for executing and analyzing real-time cell analysis data, has been released, according to US-based Agilent Technologies Inc. Agilent xCELLigence Real-Time Cell Analysis (RTCA) equipment can be used in GMP-regulated facilities thanks to this enhanced version. The xCELLigence RTCA Software Pro makes data integrity controls possible to comply with the FDA 21 CFR Part 11 and EU GMP Annex 11 regulations for digital records and electronic signatures, which are crucial for manufacturing pharmaceuticals and biopharmaceuticals. New and improved capabilities guarantee the authenticity, dependability, and trustworthiness of data and electronic records created with xCELLigence RTCA systems and their compliance with GMP production standards.




    • Oct 2023: The global leader in in vitro diagnostics, bioMérieux SA, has invested £70 million in Oxford Nanopore Technologies plc. Oxford Nanopore, which was formed from the University of Oxford lab of Professor Hagan Bayley, has created a real-time DNA/RNA sequencer that can help with precise, quick testing for infectious diseases and cancer. The business services thousands of clients in over 120 countries, representing a broad spectrum of scientific communities. Currently, the French company bioMérieux holds 3.5% of the company's shares, with plans to raise that percentage "from time to time, subject to availability and price." After the businesses announced their alliance in April, the investment aligns with Oxford Nanopore's growing emphasis on clinical markets.


    List of Companion diagnostics Key companies in the market

    • Hoffmann-La Roche Ltd (Switzerland)

    • Thermo Fisher Scientific Inc. (US)

    • Agilent Technologies, Inc. (US)

    • QIAGEN N.V. (Germany)

    • Abbott Laboratories, Inc. (US)

    • BioMérieux SA (France)

    • Leica Biosystems Nussloch GmbH (Germany)

    • Illumina, Inc. (US)

    • Myriad Genetics, Inc. (US)

    • ArcherDX, Inc. (US)